Retrospective study of alectinib in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer who had not responded to crizotinib therapy.
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2015
At a glance
- Drugs Alectinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.